Literature DB >> 12045020

Decoding implantation and menstruation: the tale of two opposing signals.

Siamak Tabibzadeh1.   

Abstract

Human endometrium is a unique tissue that undergoes sequential phases of proliferation, and secretory changes followed by tissue shedding and bleeding during menstruation. Tissue remodeling is a distinct feature of human endometrium in the secretory phase which prepares endometrium for implantation during the "receptive phase" of the cycle. A discrete dissolution of extracellular matrix (ECM) by a host of enzymes called matrix metalloproteases (MMP) is required for a successful implantation. In the absence of implantation, as a result of progesterone withdrawal, human endometrium loses its receptive state in the premenstrual period and subsequently undergoes a generalized breakdown of ECM by MMPs during menstruation. The homeostasis of ECM of endometrium and the delicate balance between its synthesis and degradation appear to be mediated by reciprocal interaction between TGF-beta and ebaf (lefty) signaling. While TGF-beta acts as a pro-fibrogenic cytokine and maintains the integrity of ECM in endometrium, expression of lefty is associated with events that lead to destruction of ECM facilitating tissue shedding.

Entities:  

Mesh:

Year:  2002        PMID: 12045020     DOI: 10.2741/A854

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  3 in total

1.  Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells.

Authors:  Nicole Kane; Marius Jones; Jan J Brosens; Philippa T K Saunders; Rodney W Kelly; Hilary O D Critchley
Journal:  Mol Endocrinol       Date:  2007-11-21

Review 2.  A critical period of progesterone withdrawal precedes menstruation in macaques.

Authors:  Ov D Slayden; Robert M Brenner
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

Review 3.  Molecular and functional aspects of menstruation in the macaque.

Authors:  Robert M Brenner; Ov D Slayden
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.